Sight Sciences Analyst Ratings
Sight Sciences Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/13/2023 | 21.95% | Morgan Stanley | $8.4 → $4 | Maintains | Equal-Weight |
| 09/12/2023 | 37.2% | B of A Securities | $10 → $4.5 | Downgrades | Neutral → Underperform |
| 09/12/2023 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 09/12/2023 | 67.68% | Piper Sandler | $15 → $5.5 | Downgrades | Overweight → Neutral |
| 08/24/2023 | 156.1% | Morgan Stanley | $12 → $8.4 | Downgrades | Overweight → Equal-Weight |
| 08/21/2023 | 143.9% | Citigroup | $9 → $8 | Maintains | Neutral |
| 08/04/2023 | 265.85% | Morgan Stanley | $15 → $12 | Maintains | Overweight |
| 07/11/2023 | 174.39% | Citigroup | $15 → $9 | Downgrades | Buy → Neutral |
| 07/10/2023 | 174.39% | Citigroup | $15 → $9 | Downgrades | Buy → Neutral |
| 06/26/2023 | 296.34% | Stifel | $15 → $13 | Maintains | Buy |
| 06/12/2023 | — | Needham | Maintains | Hold | |
| 06/06/2023 | 204.88% | B of A Securities | $13 → $10 | Maintains | Buy |
| 01/06/2023 | 357.32% | Morgan Stanley | $11 → $15 | Maintains | Overweight |
| 01/06/2023 | 357.32% | Stifel | $10 → $15 | Upgrades | Hold → Buy |
| 12/12/2022 | 357.32% | Citigroup | $10 → $15 | Maintains | Buy |
| 11/11/2022 | 235.37% | Morgan Stanley | $10 → $11 | Maintains | Overweight |
| 10/11/2022 | 204.88% | Morgan Stanley | $14 → $10 | Maintains | Overweight |
| 10/04/2022 | — | Needham | Initiates Coverage On | → Hold | |
| 08/12/2022 | 326.83% | Morgan Stanley | $17 → $14 | Maintains | Overweight |
| 08/12/2022 | 357.32% | Piper Sandler | $17 → $15 | Maintains | Overweight |
| 07/26/2022 | 204.88% | Stifel | → $10 | Initiates Coverage On | → Hold |
| 07/15/2022 | 418.29% | Morgan Stanley | $18 → $17 | Maintains | Overweight |
| 05/11/2022 | 448.78% | Morgan Stanley | $27 → $18 | Maintains | Overweight |
| 05/11/2022 | 418.29% | Piper Sandler | $23 → $17 | Maintains | Overweight |
| 03/25/2022 | 967.07% | Citigroup | $39 → $35 | Maintains | Buy |
| 02/03/2022 | — | William Blair | Initiates Coverage On | → Outperform | |
| 01/07/2022 | 723.17% | Morgan Stanley | $36 → $27 | Upgrades | Equal-Weight → Overweight |
| 08/09/2021 | 1271.95% | B of A Securities | → $45 | Initiates Coverage On | → Buy |
| 08/09/2021 | 1302.44% | Citigroup | → $46 | Initiates Coverage On | → Buy |
| 08/09/2021 | 1150% | Morgan Stanley | → $41 | Initiates Coverage On | → Equal-Weight |
| 08/09/2021 | 1241.46% | Piper Sandler | → $44 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/13/2023 | 21.95% | 摩根士丹利 | $8.4→$4 | 维护 | 等重 |
| 09/12/2023 | 37.2% | B of A证券 | $10→$4.5 | 评级下调 | 中性→表现不佳 |
| 09/12/2023 | - | 威廉·布莱尔 | 评级下调 | 跑赢→市场表现 | |
| 09/12/2023 | 67.68% | 派珀·桑德勒 | $15→$5.5 | 评级下调 | 超重→中性 |
| 2023年08月24日 | 156.1% | 摩根士丹利 | $12→$8.4 | 评级下调 | 超重→等重 |
| 2023年08月21日 | 143.9% | 花旗集团 | $9→$8 | 维护 | 中性 |
| 08/04/2023 | 265.85% | 摩根士丹利 | $15→$12 | 维护 | 超重 |
| 07/11/2023 | 174.39% | 花旗集团 | $15→$9 | 评级下调 | 购买→中性 |
| 07/10/2023 | 174.39% | 花旗集团 | $15→$9 | 评级下调 | 购买→中性 |
| 2023/06/26 | 296.34% | Stifel | $15→$13 | 维护 | 买 |
| 2023/06/12 | - | 李约瑟 | 维护 | 保持 | |
| 06/06/2023 | 204.88% | B of A证券 | $13→$10 | 维护 | 买 |
| 01/06/2023 | 357.32% | 摩根士丹利 | $11→$15 | 维护 | 超重 |
| 01/06/2023 | 357.32% | Stifel | $10→$15 | 升级 | 持有→购买 |
| 2022年12月12日 | 357.32% | 花旗集团 | $10→$15 | 维护 | 买 |
| 2022年11月11日 | 235.37% | 摩根士丹利 | $10→$11 | 维护 | 超重 |
| 2022年10月11日 | 204.88% | 摩根士丹利 | $14→$10 | 维护 | 超重 |
| 10/04/2022 | - | 李约瑟 | 开始承保 | →保留 | |
| 2022年08月12日 | 326.83% | 摩根士丹利 | $17→$14 | 维护 | 超重 |
| 2022年08月12日 | 357.32% | 派珀·桑德勒 | $17→$15 | 维护 | 超重 |
| 07/26/2022 | 204.88% | Stifel | →$10 | 开始承保 | →保留 |
| 07/15/2022 | 418.29% | 摩根士丹利 | $18→$17 | 维护 | 超重 |
| 2022年05月11日 | 448.78% | 摩根士丹利 | $27→$18 | 维护 | 超重 |
| 2022年05月11日 | 418.29% | 派珀·桑德勒 | $23→$17 | 维护 | 超重 |
| 03/25/2022 | 967.07% | 花旗集团 | $39→$35 | 维护 | 买 |
| 02/03/2022 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 01/07/2022 | 723.17% | 摩根士丹利 | $36→$27 | 升级 | 等重→超重 |
| 08/09/2021 | 1271.95% | B of A证券 | →$45 | 开始承保 | →购买 |
| 08/09/2021 | 1302.44% | 花旗集团 | →$46 | 开始承保 | →购买 |
| 08/09/2021 | 1150% | 摩根士丹利 | →$41 | 开始承保 | →等重 |
| 08/09/2021 | 1241.46% | 派珀·桑德勒 | →$44 | 开始承保 | →超重 |
What is the target price for Sight Sciences (SGHT)?
视觉科学(SGHT)的目标价格是多少？
The latest price target for Sight Sciences (NASDAQ: SGHT) was reported by Morgan Stanley on September 13, 2023. The analyst firm set a price target for $4.00 expecting SGHT to rise to within 12 months (a possible 21.95% upside). 18 analyst firms have reported ratings in the last year.
视科(纳斯达克代码：SGHT)的最新目标价是由摩根士丹利于2023年9月13日报道的。这家分析公司将目标价定为4.00美元，预计SGHT将在12个月内上涨至21.95%(可能上涨21.95%)。去年有18家分析公司公布了评级。
What is the most recent analyst rating for Sight Sciences (SGHT)?
视觉科学(SGHT)的最新分析师评级是多少？
The latest analyst rating for Sight Sciences (NASDAQ: SGHT) was provided by Morgan Stanley, and Sight Sciences maintained their equal-weight rating.
视科(纳斯达克股票代码：SGHT)最新分析师评级由摩根士丹利提供，视科维持同等权重评级。
When is the next analyst rating going to be posted or updated for Sight Sciences (SGHT)?
视觉科学(SGHT)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sight Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sight Sciences was filed on September 13, 2023 so you should expect the next rating to be made available sometime around September 13, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Sight Sciences的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。视觉科学的上一次评级是在2023年9月13日提交的，所以你应该预计下一次评级将在2024年9月13日左右提供。
Is the Analyst Rating Sight Sciences (SGHT) correct?
分析师对视觉科学(SGHT)的评级正确吗？
While ratings are subjective and will change, the latest Sight Sciences (SGHT) rating was a maintained with a price target of $8.40 to $4.00. The current price Sight Sciences (SGHT) is trading at is $3.28, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的视觉科学(SGHT)评级维持不变，目标价在8.40美元至4.00美元之间。Sight Sciences(SGHT)目前的股价为3.28美元，超出了分析师的预测区间。